199 related articles for article (PubMed ID: 38672512)
1. Effects of Cannabidiol, ∆9-Tetrahydrocannabinol, and WIN 55-212-22 on the Viability of Canine and Human Non-Hodgkin Lymphoma Cell Lines.
Omer S; Pathak S; Mansour M; Nadar R; Bowen D; Dhanasekaran M; Pondugula SR; Boothe D
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672512
[TBL] [Abstract][Full Text] [Related]
2. Validating the anti-lymphoma pharmacodynamic actions of the endocannabinoids on canine non-Hodgkin lymphoma.
Omer S; Pathak S; Nadar R; Bowen D; Sandey M; Dhanasekaran M; Pondugula S; Mansour M; Boothe D
Life Sci; 2023 Aug; 327():121862. PubMed ID: 37330042
[TBL] [Abstract][Full Text] [Related]
3. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid-induced changes in respiration of brain mitochondria.
Fišar Z; Singh N; Hroudová J
Toxicol Lett; 2014 Nov; 231(1):62-71. PubMed ID: 25195527
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis.
Fonseca BM; Correia-da-Silva G; Teixeira NA
J Physiol Biochem; 2018 May; 74(2):261-272. PubMed ID: 29441458
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
Di Marzo V; Berrendero F; Bisogno T; González S; Cavaliere P; Romero J; Cebeira M; Ramos JA; Fernández-Ruiz JJ
J Neurochem; 2000 Apr; 74(4):1627-35. PubMed ID: 10737621
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent.
Sreevalsan S; Joseph S; Jutooru I; Chadalapaka G; Safe SH
Anticancer Res; 2011 Nov; 31(11):3799-807. PubMed ID: 22110202
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83.
Cerretani D; Collodel G; Brizzi A; Fiaschi AI; Menchiari A; Moretti E; Moltoni L; Micheli L
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752303
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of monoamine oxidase activity by cannabinoids.
Fisar Z
Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):563-72. PubMed ID: 20401651
[TBL] [Abstract][Full Text] [Related]
11. Unveiling the angiogenic effects of cannabinoids: Enhancers or inhibitors?
Maia J; Fonseca BM; Teixeira N; Correia-da-Silva G
Biochem Pharmacol; 2023 Sep; 215():115686. PubMed ID: 37463627
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development.
Shoeib AM; Yarbrough AL; Ford BM; Franks LN; Urbaniak A; Hensley LL; Benson LN; Mu S; Radominska-Pandya A; Prather PL
Life Sci; 2021 Nov; 285():119993. PubMed ID: 34592231
[TBL] [Abstract][Full Text] [Related]
13. On the effects of CP 55-940 and other cannabinoid receptor agonists in C6 and U373 cell lines.
Ortega A; Rangel-López E; Hidalgo-Miranda A; Morales A; Ruiz-García E; Meneses-García A; Herrera-Gómez A; Aguilar-Ponce JL; González-Herrera IG; Guevara-Salazar P; Prospero-García O; Del Angel SA
Toxicol In Vitro; 2015 Oct; 29(7):1941-51. PubMed ID: 26255146
[TBL] [Abstract][Full Text] [Related]
14. Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER
Amaral C; Trouille FM; Almeida CF; Correia-da-Silva G; Teixeira N
J Steroid Biochem Mol Biol; 2021 Jun; 210():105876. PubMed ID: 33722705
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells.
Giudice ED; Rinaldi L; Passarotto M; Facchinetti F; D'Arrigo A; Guiotto A; Carbonare MD; Battistin L; Leon A
J Leukoc Biol; 2007 Jun; 81(6):1512-22. PubMed ID: 17339608
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of endogenous, phyto and synthetic cannabinoids on thrombogenesis and platelet activity.
Grambow E; Strüder D; Klar E; Hinz B; Vollmar B
Biofactors; 2016 Nov; 42(6):581-590. PubMed ID: 27151562
[TBL] [Abstract][Full Text] [Related]
18. Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study.
Chester LA; Englund A; Chesney E; Oliver D; Wilson J; Sovi S; Dickens AM; Oresic M; Linderman T; Hodsoll J; Minichino A; Strang J; Murray RM; Freeman TP; McGuire P
Cannabis Cannabinoid Res; 2024 Feb; 9(1):188-198. PubMed ID: 36493386
[No Abstract] [Full Text] [Related]
19. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
McPartland JM; Duncan M; Di Marzo V; Pertwee RG
Br J Pharmacol; 2015 Feb; 172(3):737-53. PubMed ID: 25257544
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma.
Flygare J; Gustafsson K; Kimby E; Christensson B; Sander B
FEBS Lett; 2005 Dec; 579(30):6885-9. PubMed ID: 16337199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
